{"id":"W2764339126","doi":"10.1182/blood-2017-05-780049","title":"Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":241,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"Takeda Oncology","keywords":"Brentuximab vedotin; Anaplastic large-cell lymphoma; Medicine; Internal medicine; Oncology; Refractory (planetary science); Lymphoma; Hodgkin lymphoma; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001200438,0.000183697,0.0004382443,0.0001009053,0.00008779899,0.00002060725,0.0001465473,0.00009933574,0.00001785478],"category_scores_gemma":[0.0002119411,0.0001199845,0.00006013453,0.00007389817,0.00004844875,0.00008698281,0.00006026474,0.00005676432,0.00004516677],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001157935,"about_ca_system_score_gemma":0.000195779,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002162917,"about_ca_topic_score_gemma":0.0001319543,"domain_scores_codex":[0.998646,0.00004014458,0.0003820823,0.0003285829,0.0003252637,0.000277926],"domain_scores_gemma":[0.9985235,0.0001025563,0.0003831135,0.0007726977,0.0001062066,0.0001119703],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006221405,0.0214352,0.9699416,0.0002873428,0.0001504884,0.0003401812,0.0003260565,8.132855e-7,0.00007539966,0.00001563433,0.000437873,0.0007680618],"study_design_scores_gemma":[0.1672286,0.003050297,0.8262095,0.0009468799,0.0002702865,0.00001198263,0.00008082703,0.000007510699,0.001858375,0.000001273159,0.0002175641,0.0001168685],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966555,0.0001529277,4.840961e-7,0.00003266323,0.0001017489,0.000513187,0.0001707816,0.00002143189,0.002351233],"genre_scores_gemma":[0.9990985,0.00004639851,0.0001366497,0.00002138447,0.00003759156,0.00003033232,0.00008352962,0.00002565497,0.0005199621],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1610072,"threshold_uncertainty_score":0.4892825,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007575507668794034,"score_gpt":0.2232837674219153,"score_spread":0.2157082597531213,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}